Cabergoline: what it is for

Cabergoline treats diagnosed high-prolactin disorders. Bodybuilders also look it up for libido changes, breast symptoms or alongside Deca and tren—but those clues alone do not identify a prolactin problem.

The useful question is why prolactin is elevated and whether treating it will help. Cabergoline is not an estrogen blocker or an automatic add-on to a steroid schedule.

Labeled starting dose Checks and side effects
Connect the result to a cause
Symptoms
What changed? Blood result
Value + context
Clinical assessment

Medicines · sampling · other causes

Treat a defined disorder

Cabergoline is one treatment when indicated.

Low libido or a steroid name cannot replace this assessment.

Dose, frequency and duration

0.25 mg

Starting amount per dose

By mouth, twice weekly—not twice daily. This is a clinical label example.

≥4 weeks apart

Dose changes

The prescriber adjusts to measured prolactin response and tolerability.

Duration

Depends on the diagnosis and reassessment, not the length of a steroid cycle.

Cabergoline label. This is a clinical starting-dose example, not preventive “caber” for everyone taking a 19-nor. Heart-valve assessment is part of the label’s treatment requirements.

What can raise prolactin besides a steroid?

Prolactin can be affected by medicines and several medical conditions. Sampling stress and macroprolactin—a form that can contribute to a measured result—may also affect interpretation. Guidelines distinguish assessment of the cause from treatment of a prolactinoma or drug-induced elevation. Endocrine Society guideline

For an unexpected result, bring the report and a full medication list, including hormones, supplements and any recent changes. A clinician decides whether repeat testing or other investigation is appropriate. Do not stop another prescribed medicine merely because it might influence prolactin.

Why heart-valve checks matter

US prescribing information lists hyperprolactinemic disorders, including those associated with pituitary adenomas. It calls for cardiovascular assessment, including echocardiography, before treatment and ongoing monitoring for valve disease. It also warns about fibrotic disorders, low blood pressure on standing and impulse-control problems. Cabergoline label, revised June 2025

The monitoring is part of using the medicine for a clinical reason. A small tablet or infrequent schedule does not eliminate the need to consider these risks.

Changes in urges, spending or sexual behavior

New compulsive gambling, spending, sexual behavior or other unusually strong urges are relevant medication symptoms. A person may experience them as a change in motivation rather than as a side effect. Tell the prescriber promptly; a friend or partner may notice the change first.

Dizziness or faintness on standing also deserves attention, especially when other blood-pressure-lowering medicines are involved. Do not use a concentration curve to decide that such a symptom is harmless.

How will you know treatment is working?

A drug can continue to act between doses, but treatment depends on diagnosis, response and tolerability. The measured decline of cabergoline cannot predict an individual’s prolactin result or establish that another tablet is needed after a particular steroid injection.

The same applies to stopping: drug concentration and recovery of hormone secretion are not identical clocks. Keep dose decisions with the prescriber and make the exposure history clear.

Common questions

Does every 19-nor steroid increase prolactin? A chemical class does not diagnose an individual’s hormone abnormality. The evidence here does not justify automatic cabergoline.

Is low libido enough reason to use it? No. Sexual symptoms have many possible causes and are not specific to prolactin.

Can a normal prolactin result mean all hormone problems are solved? No. It answers one measurement question; testosterone, fertility and symptoms are separate.

Can cabergoline treat a breast lump? A breast lump is not a diagnosis of high prolactin. Have it assessed rather than choosing cabergoline from the other steroids in a schedule.

How is it different from bromocriptine? Both are dopamine agonists used for prolactin disorders, but they are different medicines with their own doses and tolerability. A prescriber chooses between them; do not exchange tablets milligram for milligram. Endocrine Society explanation.

Is cabergoline the same as an AI? No. Cabergoline targets dopamine signaling and prolactin secretion; an AI reduces estrogen synthesis. The ancillary map compares their roles.

Sources and review notes

Checked October 12, 2026. The starting dose and precautions come from the US label for hyperprolactinemic disorders. They do not establish preventive use with nandrolone or trenbolone.